{"transactions":[{"id":4639807,"issuer":{"id":184308,"kind":"organization","name":"TRex Bio, Inc.","symbol":"TRXB"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-10-13T22:31:34.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":false,"shares":161828,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 13, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 3.8649-to-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 13, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 3.8649-to-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 13, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 3.8649-to-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":41871},"source":{"system":"sec-edgar","filing":"0001193125-26-420734","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2139097/000119312526420734/ownership.xml","form_type":"4"}},{"id":4639806,"issuer":{"id":184308,"kind":"organization","name":"TRex Bio, Inc.","symbol":"TRXB"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-13T22:31:34.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":true,"shares":41871,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 13, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a 3.8649-to-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":41871,"source":{"system":"sec-edgar","filing":"0001193125-26-420734","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2139097/000119312526420734/ownership.xml","form_type":"4"}},{"id":4638348,"issuer":{"id":184308,"kind":"organization","name":"TRex Bio, Inc.","symbol":"TRXB"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-10-09T01:53:47.000Z","date":"2026-10-08","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on October 8, 2027, subject to the reporting person's continued service through such date."}],"balance_after":17500,"derivative":{"exercise_price":14,"expiration_date":"2036-10-08","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001193125-26-418302","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2139097/000119312526418302/ownership.xml","form_type":"4"}},{"id":4618199,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-09-15T20:44:26.000Z","date":"2026-09-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":49.68,"value":248400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased at prices ranging from $49.38 to $49.82.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":597724,"source":{"system":"sec-edgar","filing":"0001216955-26-000021","document":"wk-form4_1789505061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000121695526000021/wk-form4_1789505061.xml","form_type":"4"}},{"id":681898,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-08-19T20:37:12.000Z","date":"2026-08-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":46.28,"value":231400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased at prices ranging from $46.12 to $46.50.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":592724,"source":{"system":"sec-edgar","filing":"0001216955-26-000019","document":"wk-form4_1787171829.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000019/wk-form4_1787171829.xml","form_type":"4"}},{"id":788805,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-05-07T20:32:02.000Z","date":"2026-05-06","kind":"purchase","planned":false,"acquired":true,"shares":3511,"price":46.74,"value":164104.14,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased at prices ranging from $46.44 to $46.96.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":587724,"source":{"system":"sec-edgar","filing":"0001216955-26-000017","document":"wk-form4_1778185919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000017/wk-form4_1778185919.xml","form_type":"4"}},{"id":788804,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-05-07T20:32:02.000Z","date":"2026-05-06","kind":"purchase","planned":false,"acquired":true,"shares":3989,"price":45.99,"value":183454.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased at prices ranging from $45.34 to $46.30.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":584213,"source":{"system":"sec-edgar","filing":"0001216955-26-000017","document":"wk-form4_1778185919.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000017/wk-form4_1778185919.xml","form_type":"4"}},{"id":790281,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-05-06T20:48:36.000Z","date":"2026-05-05","kind":"purchase","planned":false,"acquired":true,"shares":1606,"price":43.7,"value":70182.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were purchased at prices ranging from $43.41 to $43.97.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":580224,"source":{"system":"sec-edgar","filing":"0001216955-26-000015","document":"wk-form4_1778100512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000015/wk-form4_1778100512.xml","form_type":"4"}},{"id":790280,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-05-06T20:48:36.000Z","date":"2026-05-05","kind":"purchase","planned":false,"acquired":true,"shares":3832,"price":42.76,"value":163856.32,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased at prices ranging from $42.38 to $43.35.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":578618,"source":{"system":"sec-edgar","filing":"0001216955-26-000015","document":"wk-form4_1778100512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000015/wk-form4_1778100512.xml","form_type":"4"}},{"id":790279,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-05-06T20:48:36.000Z","date":"2026-05-05","kind":"purchase","planned":false,"acquired":true,"shares":2062,"price":41.89,"value":86377.18,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased at prices ranging from $41.36 to $42.36.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":574786,"source":{"system":"sec-edgar","filing":"0001216955-26-000015","document":"wk-form4_1778100512.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000015/wk-form4_1778100512.xml","form_type":"4"}},{"id":792414,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-05-05T20:32:41.000Z","date":"2026-05-04","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":41.02,"value":410200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased at prices ranging from $40.64 to $41.58.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":572724,"source":{"system":"sec-edgar","filing":"0001216955-26-000013","document":"wk-form4_1778013158.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000013/wk-form4_1778013158.xml","form_type":"4"}},{"id":905717,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-02-13T21:45:00.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":7700,"price":54.31,"value":418187.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were purchased at prices ranging from $54.02 to $54.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding\nthe number of shares purchased at each separate price."}],"balance_after":562724,"source":{"system":"sec-edgar","filing":"0001216955-26-000011","document":"wk-form4_1771019097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000011/wk-form4_1771019097.xml","form_type":"4"}},{"id":905716,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-02-13T21:45:00.000Z","date":"2026-02-12","kind":"purchase","planned":false,"acquired":true,"shares":17300,"price":53.74,"value":929702.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were purchased at prices ranging from $53.49 to $53.97. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding\nthe number of shares purchased at each separate price."}],"balance_after":555024,"source":{"system":"sec-edgar","filing":"0001216955-26-000011","document":"wk-form4_1771019097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000011/wk-form4_1771019097.xml","form_type":"4"}},{"id":931357,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-01-26T23:45:17.000Z","date":"2026-01-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":35075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the forfeiture of a portion of a restricted stock award previously reported."}],"balance_after":537724,"source":{"system":"sec-edgar","filing":"0001216955-26-000009","document":"wk-form4_1769471114.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000009/wk-form4_1769471114.xml","form_type":"4"}},{"id":931356,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-01-26T23:45:17.000Z","date":"2026-01-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the forfeiture of a portion of a restricted stock award previously reported."}],"balance_after":572799,"source":{"system":"sec-edgar","filing":"0001216955-26-000009","document":"wk-form4_1769471114.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000009/wk-form4_1769471114.xml","form_type":"4"}},{"id":940317,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-01-13T21:43:23.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":100056,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":587470,"source":{"system":"sec-edgar","filing":"0001216955-26-000007","document":"wk-form4_1768340600.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000007/wk-form4_1768340600.xml","form_type":"4"}},{"id":952788,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-01-06T00:41:55.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":31270,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":487414,"source":{"system":"sec-edgar","filing":"0001216955-26-000003","document":"wk-form4_1767660111.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000121695526000003/wk-form4_1767660111.xml","form_type":"4"}},{"id":1182881,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-02T21:32:04.000Z","date":"2025-04-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2951,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit (each, a \"Company RSU\") represented a contingent right to re-ceive one Company Share."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each Company RSU that was then outstanding as of immediately prior to the Effective Time, whether vested or unvested, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggre-gate number of Company Shares underlying such Company RSU immediately prior to the Effective Time and (ii) the Merger Consideration. Notwithstanding the foregoing, in the case of each Company RSU granted in 2025, the Merger Consideration will instead be payable at the time the original Company RSU would have vested, subject to accelerated vesting in certain circumstances."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each Company RSU that was then outstanding as of immediately prior to the Effective Time, whether vested or unvested, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggre-gate number of Company Shares underlying such Company RSU immediately prior to the Effective Time and (ii) the Merger Consideration. Notwithstanding the foregoing, in the case of each Company RSU granted in 2025, the Merger Consideration will instead be payable at the time the original Company RSU would have vested, subject to accelerated vesting in certain circumstances."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Not applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2951},"source":{"system":"sec-edgar","filing":"0000950170-25-049596","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017025049596/ownership.xml","form_type":"4"}},{"id":1182880,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T21:32:04.000Z","date":"2025-04-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a \"Company Option\")  that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"(Continued from Footnote 4) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Considera-tion was canceled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each option to purchase Company Shares (each, a \"Company Option\")  that was then outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, and which had a per share exercise price that was less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash (without interest) equal to the product of (i) the aggregate number of Company Shares underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"(Continued from Footnote 4) In addition, upon the terms and subject to the conditions set forth in the Merger Agreement, at the Effective Time, each other Company Option with a per share exercise price that equaled or exceeded the amount of the Merger Considera-tion was canceled for no consideration."}],"balance_after":0,"derivative":{"exercise_price":67.77,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":4322},"source":{"system":"sec-edgar","filing":"0000950170-25-049596","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017025049596/ownership.xml","form_type":"4"}},{"id":1182879,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T21:32:04.000Z","date":"2025-04-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"price":132,"value":1320000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2025 (the \"Merger Agreement\"), by and among Intra-Cellular Therapies, Inc. (the \"Company\"), Johnson & Johnson, a New Jersey corporation (\"Parent\"), and Fleming Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which, subject to the terms and condi-tions thereof, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as a wholly owned subsidiary of Parent, effective as of April 2, 2025 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) At the Effective Time, each share of common stock, par val-ue $0.0001 per share, of the Company (\"Company Shares\") issued and outstanding im-mediately prior to the Effective Time (other than certain Company Shares canceled pur-suant to the Merger Agreement and Company Shares with respect to which appraisal rights had been properly and validly exercised) was automatically converted into the right to receive an amount equal to $132.00 per share in cash (the \"Merger Consideration\"), without interest thereon and less any applicable tax withholdings."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2025 (the \"Merger Agreement\"), by and among Intra-Cellular Therapies, Inc. (the \"Company\"), Johnson & Johnson, a New Jersey corporation (\"Parent\"), and Fleming Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which, subject to the terms and condi-tions thereof, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as a wholly owned subsidiary of Parent, effective as of April 2, 2025 (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) At the Effective Time, each share of common stock, par val-ue $0.0001 per share, of the Company (\"Company Shares\") issued and outstanding im-mediately prior to the Effective Time (other than certain Company Shares canceled pur-suant to the Merger Agreement and Company Shares with respect to which appraisal rights had been properly and validly exercised) was automatically converted into the right to receive an amount equal to $132.00 per share in cash (the \"Merger Consideration\"), without interest thereon and less any applicable tax withholdings."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Represents securities held of record by Alexandria Real Estate Equities, Inc. The reporting person is the Executive Chairman & Founder of Alexandria Real Estate Equities, Inc. and may therefore be deemed to have voting and investment power with respect to the shares owned by Alexandria Real Estate Equities, Inc. The reporting person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-049596","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017025049596/ownership.xml","form_type":"4"}},{"id":1182878,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T21:32:04.000Z","date":"2025-04-02","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":48238,"price":132,"value":6367416.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2025 (the \"Merger Agreement\"), by and among Intra-Cellular Therapies, Inc. (the \"Company\"), Johnson & Johnson, a New Jersey corporation (\"Parent\"), and Fleming Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which, subject to the terms and condi-tions thereof, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as a wholly owned subsidiary of Parent, effective as of April 2, 2025 (the \"Effective Time\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) At the Effective Time, each share of common stock, par val-ue $0.0001 per share, of the Company (\"Company Shares\") issued and outstanding im-mediately prior to the Effective Time (other than certain Company Shares canceled pur-suant to the Merger Agreement and Company Shares with respect to which appraisal rights had been properly and validly exercised) was automatically converted into the right to receive an amount equal to $132.00 per share in cash (the \"Merger Consideration\"), without interest thereon and less any applicable tax withholdings."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2025 (the \"Merger Agreement\"), by and among Intra-Cellular Therapies, Inc. (the \"Company\"), Johnson & Johnson, a New Jersey corporation (\"Parent\"), and Fleming Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (\"Merger Sub\"), pursuant to which, subject to the terms and condi-tions thereof, Merger Sub merged with and into the Company (the \"Merger\"), with the Company surviving the Merger as a wholly owned subsidiary of Parent, effective as of April 2, 2025 (the \"Effective Time\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) At the Effective Time, each share of common stock, par val-ue $0.0001 per share, of the Company (\"Company Shares\") issued and outstanding im-mediately prior to the Effective Time (other than certain Company Shares canceled pur-suant to the Merger Agreement and Company Shares with respect to which appraisal rights had been properly and validly exercised) was automatically converted into the right to receive an amount equal to $132.00 per share in cash (the \"Merger Consideration\"), without interest thereon and less any applicable tax withholdings."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-049596","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017025049596/ownership.xml","form_type":"4"}},{"id":1242639,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-26T23:01:04.000Z","date":"2025-02-24","kind":"exercise","planned":false,"acquired":false,"shares":7009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All shares underlying this option have vested."}],"balance_after":0,"derivative":{"exercise_price":63.79,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":7009},"source":{"system":"sec-edgar","filing":"0000950170-25-028030","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017025028030/ownership.xml","form_type":"4"}},{"id":1242638,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-26T23:01:04.000Z","date":"2025-02-24","kind":"exercise","planned":false,"acquired":true,"shares":7009,"price":63.79,"value":447104.11,"ownership":{"direct":true},"balance_after":48238,"source":{"system":"sec-edgar","filing":"0000950170-25-028030","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017025028030/ownership.xml","form_type":"4"}},{"id":1303757,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2025-01-14T21:37:43.000Z","date":"2025-01-10","kind":"grant","planned":false,"acquired":true,"shares":46207,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":456144,"source":{"system":"sec-edgar","filing":"0001035443-25-000037","document":"wk-form4_1736890656.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544325000037/wk-form4_1736890656.xml","form_type":"4"}},{"id":1315954,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2025-01-03T21:51:38.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":15610,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":409937,"source":{"system":"sec-edgar","filing":"0001035443-25-000018","document":"wk-form4_1735941092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544325000018/wk-form4_1735941092.xml","form_type":"4"}},{"id":1315953,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2025-01-03T21:51:38.000Z","date":"2024-12-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the forfeiture of a portion of a restricted stock award previously reported."}],"balance_after":394327,"source":{"system":"sec-edgar","filing":"0001035443-25-000018","document":"wk-form4_1735941092.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544325000018/wk-form4_1735941092.xml","form_type":"4"}},{"id":1469390,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-25T22:05:06.000Z","date":"2024-06-23","kind":"exercise","planned":false,"acquired":false,"shares":1567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 23, 2023, the reporting person was granted 1,567 restricted stock units, which vested on the first anniversary of the grant date (June 23, 2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 23, 2023, the reporting person was granted 1,567 restricted stock units, which vested on the first anniversary of the grant date (June 23, 2024)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1567},"source":{"system":"sec-edgar","filing":"0000950170-24-077469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024077469/ownership.xml","form_type":"4"}},{"id":1469389,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-25T22:05:06.000Z","date":"2024-06-23","kind":"exercise","planned":false,"acquired":true,"shares":1567,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":41229,"source":{"system":"sec-edgar","filing":"0000950170-24-077469","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024077469/ownership.xml","form_type":"4"}},{"id":1474877,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-18T22:01:36.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":4322,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4322,"derivative":{"exercise_price":67.77,"exercise_date":"2025-06-14","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":4322},"source":{"system":"sec-edgar","filing":"0000950170-24-075079","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024075079/ownership.xml","form_type":"4"}},{"id":1474876,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-18T22:01:36.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":2951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 14, 2024, the reporting person was granted 2,951 restricted stock units, vesting on the first anniversary of the grant date (June 14, 2025)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 14, 2024, the reporting person was granted 2,951 restricted stock units, vesting on the first anniversary of the grant date (June 14, 2025)."}],"balance_after":2951,"derivative":{"underlying":"Common Stock","underlying_shares":2951},"source":{"system":"sec-edgar","filing":"0000950170-24-075079","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024075079/ownership.xml","form_type":"4"}},{"id":1486387,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T20:12:11.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the Restricted Stock Units shall vest on a quarterly basis from June 6, 2024 until the earlier of (i) the first anniversary of the date of grant and (ii) the date of the issuer's next annual stockholder meeting, in each case, subject to the reporting person's continuous service as of each such date."}],"balance_after":498414,"source":{"system":"sec-edgar","filing":"0000950170-24-070634","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024070634/ownership.xml","form_type":"4"}},{"id":1554274,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-04-02T20:47:51.000Z","date":"2024-03-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":5400,"price":128.91,"value":696114.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock."}],"balance_after":413483,"source":{"system":"sec-edgar","filing":"0001035443-24-000119","document":"wk-form4_1712090852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544324000119/wk-form4_1712090852.xml","form_type":"4"}},{"id":1554273,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-04-02T20:47:51.000Z","date":"2024-03-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10655,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the forfeiture of a portion of a restricted stock award previously reported."}],"balance_after":418883,"source":{"system":"sec-edgar","filing":"0001035443-24-000119","document":"wk-form4_1712090852.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544324000119/wk-form4_1712090852.xml","form_type":"4"}},{"id":1612900,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-02-28T21:31:50.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":7500,"price":118.92,"value":891900.0,"ownership":{"direct":true},"balance_after":429538,"source":{"system":"sec-edgar","filing":"0001035443-24-000079","document":"wk-form4_1709155889.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544324000079/wk-form4_1709155889.xml","form_type":"4"}},{"id":1615156,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-28T00:57:35.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":16757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares underlying this option have vested."}],"balance_after":0,"derivative":{"exercise_price":55.48,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":16757},"source":{"system":"sec-edgar","filing":"0000950170-24-021563","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024021563/ownership.xml","form_type":"4"}},{"id":1615155,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-02-28T00:57:35.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All shares underlying this option have vested."}],"balance_after":0,"derivative":{"exercise_price":43.45,"expiration_date":"2031-06-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-021563","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024021563/ownership.xml","form_type":"4"}},{"id":1615154,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T00:57:35.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":299,"price":69.6,"value":20810.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.53 to $69.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":39662,"source":{"system":"sec-edgar","filing":"0000950170-24-021563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024021563/ownership.xml","form_type":"4"}},{"id":1615153,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T00:57:35.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":17658,"price":69.07,"value":1219638.06,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.53 to $69.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":39961,"source":{"system":"sec-edgar","filing":"0000950170-24-021563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024021563/ownership.xml","form_type":"4"}},{"id":1615152,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T00:57:35.000Z","date":"2024-02-26","kind":"sale","planned":false,"acquired":false,"shares":8371,"price":67.83,"value":567804.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.53 to $68.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":57619,"source":{"system":"sec-edgar","filing":"0000950170-24-021563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024021563/ownership.xml","form_type":"4"}},{"id":1615151,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T00:57:35.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":16757,"price":55.48,"value":929678.36,"ownership":{"direct":true},"balance_after":65990,"source":{"system":"sec-edgar","filing":"0000950170-24-021563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024021563/ownership.xml","form_type":"4"}},{"id":1615150,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-28T00:57:35.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":43.45,"value":869000.0,"ownership":{"direct":true},"balance_after":49233,"source":{"system":"sec-edgar","filing":"0000950170-24-021563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000095017024021563/ownership.xml","form_type":"4"}},{"id":1680210,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-12T21:26:01.000Z","date":"2024-01-10","kind":"grant","planned":false,"acquired":true,"shares":35064,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":437038,"source":{"system":"sec-edgar","filing":"0001035443-24-000046","document":"wk-form4_1705094747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544324000046/wk-form4_1705094747.xml","form_type":"4"}},{"id":1683065,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-09T22:04:31.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":401974,"source":{"system":"sec-edgar","filing":"0001035443-24-000043","document":"wk-form4_1704837862.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544324000043/wk-form4_1704837862.xml","form_type":"4"}},{"id":1688638,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2024-01-04T21:54:54.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":47620,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":398974,"source":{"system":"sec-edgar","filing":"0001035443-24-000026","document":"wk-form4_1704405282.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544324000026/wk-form4_1704405282.xml","form_type":"4"}},{"id":1777125,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-09-20T00:08:34.000Z","date":"2023-09-15","kind":"exercise","planned":false,"acquired":false,"shares":12375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.05,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":12375},"source":{"system":"sec-edgar","filing":"0001209191-23-050097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919123050097/doc4.xml","form_type":"4"}},{"id":1777124,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-20T00:08:34.000Z","date":"2023-09-15","kind":"exercise","planned":false,"acquired":true,"shares":12375,"price":1.05,"value":12993.75,"ownership":{"direct":true},"balance_after":453414,"source":{"system":"sec-edgar","filing":"0001209191-23-050097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919123050097/doc4.xml","form_type":"4"}},{"id":1843342,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-27T21:11:16.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":7009,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7009,"derivative":{"exercise_price":63.79,"exercise_date":"2024-06-23","expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":7009},"source":{"system":"sec-edgar","filing":"0001209191-23-039927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919123039927/doc4.xml","form_type":"4"}},{"id":1843341,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-27T21:11:16.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":1567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 23, 2023, the reporting person was granted 1,567 restricted stock units, vesting on the first anniversary of the grant date (June 23, 2024)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 23, 2023, the reporting person was granted 1,567 restricted stock units, vesting on the first anniversary of the grant date (June 23, 2024)."}],"balance_after":1567,"derivative":{"underlying":"Common Stock","underlying_shares":1567},"source":{"system":"sec-edgar","filing":"0001209191-23-039927","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919123039927/doc4.xml","form_type":"4"}},{"id":1861959,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-09T01:03:11.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the Restricted Stock Units shall vest on each of September 6, 2023, December 6, 2023, March 6, 2024 and the date which is the earlier of June 6, 2024 and the 2024 annual stockholder meeting, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":441039,"source":{"system":"sec-edgar","filing":"0001209191-23-035599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919123035599/doc4.xml","form_type":"4"}},{"id":1898423,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-05-10T20:35:54.000Z","date":"2023-05-08","kind":"sale","planned":false,"acquired":false,"shares":7500,"price":122.2,"value":916500.0,"ownership":{"direct":true},"balance_after":351354,"source":{"system":"sec-edgar","filing":"0001035443-23-000205","document":"wf-form4_168375093898574.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000205/wf-form4_168375093898574.xml","form_type":"4"}},{"id":1929437,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-04-04T20:53:16.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":10015,"price":125.59,"value":1257783.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock."}],"balance_after":358854,"source":{"system":"sec-edgar","filing":"0001035443-23-000149","document":"wf-form4_168064157617692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000149/wf-form4_168064157617692.xml","form_type":"4"}},{"id":1929436,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-04-04T20:53:16.000Z","date":"2023-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the forfeiture of a portion of a restricted stock award previously reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The number of shares beneficially owned by the reporting person prior to the reported transactions differs from the amount reflected on his most recent Form 4, which amount was overstated by 13,353 shares, representing the net effect of previously unreported transactions effected between 2000 and 2006.  These previous unreported transactions were the result of recently discovered administrative errors and not any error by the reporting person."}],"balance_after":368869,"source":{"system":"sec-edgar","filing":"0001035443-23-000149","document":"wf-form4_168064157617692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000149/wf-form4_168064157617692.xml","form_type":"4"}},{"id":2025055,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-02-09T21:58:04.000Z","date":"2023-02-07","kind":"sale","acquired":false,"shares":9000,"price":168,"value":1512000.0,"ownership":{"direct":true},"balance_after":388729,"source":{"system":"sec-edgar","filing":"0001035443-23-000116","document":"wf-form4_167597986424585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000116/wf-form4_167597986424585.xml","form_type":"4"}},{"id":2040578,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-31T21:30:42.000Z","date":"2023-01-27","kind":"tax_withholding","acquired":false,"shares":5608,"price":160.68,"value":901093.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock."}],"balance_after":397729,"source":{"system":"sec-edgar","filing":"0001035443-23-000103","document":"wf-form4_167520061271620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000103/wf-form4_167520061271620.xml","form_type":"4"}},{"id":2055830,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-12T21:25:33.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":24051,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":403337,"source":{"system":"sec-edgar","filing":"0001035443-23-000069","document":"wf-form4_167355871923581.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000069/wf-form4_167355871923581.xml","form_type":"4"}},{"id":2063369,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2023-01-05T21:28:11.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":42260,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":379286,"source":{"system":"sec-edgar","filing":"0001035443-23-000051","document":"wf-form4_167295406898882.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544323000051/wf-form4_167295406898882.xml","form_type":"4"}},{"id":2078568,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-21T21:06:49.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":5000,"price":50.82,"value":254100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.81 to $50.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":29233,"source":{"system":"sec-edgar","filing":"0001209191-22-062324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122062324/doc4.xml","form_type":"4"}},{"id":2086825,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-12-14T21:22:36.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":6500,"price":150,"value":975000.0,"ownership":{"direct":true},"balance_after":337026,"source":{"system":"sec-edgar","filing":"0001035443-22-000330","document":"wf-form4_167105292770977.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000330/wf-form4_167105292770977.xml","form_type":"4"}},{"id":2093604,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-12-07T21:37:20.000Z","date":"2022-12-05","kind":"sale","acquired":false,"shares":2500,"price":152,"value":380000.0,"ownership":{"direct":true},"balance_after":343526,"source":{"system":"sec-edgar","filing":"0001035443-22-000325","document":"wf-form4_167044902671724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000325/wf-form4_167044902671724.xml","form_type":"4"}},{"id":2122106,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-08T21:12:52.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":5000,"price":52.1117,"value":260558.5,"ownership":{"direct":true},"balance_after":34233,"source":{"system":"sec-edgar","filing":"0001209191-22-056091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122056091/doc4.xml","form_type":"4"}},{"id":2122105,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-08T21:12:52.000Z","date":"2022-11-07","kind":"sale","acquired":false,"shares":5000,"price":52.4929,"value":262464.5,"ownership":{"direct":true},"balance_after":39233,"source":{"system":"sec-edgar","filing":"0001209191-22-056091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122056091/doc4.xml","form_type":"4"}},{"id":2157143,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-17T01:02:09.000Z","date":"2021-04-14","kind":"exercise","acquired":false,"shares":13071,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"13,071 shares subject to the options were vested as of April 13, 2021, with one thirty-sixth (1/36th) of the remaining shares subject to the options vesting each month thereafter, subject to the reporting person continuing to provide service through each such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"The Original Form 4 incorrectly reported the number of options beneficially owned following the reported transaction as 7,839 due to an administrative error."}],"balance_after":7389,"derivative":{"exercise_price":10,"expiration_date":"2029-05-12","underlying":"Common Stock","underlying_shares":13071},"source":{"system":"sec-edgar","filing":"0001209191-22-050426","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050426/doc4a.xml","form_type":"4/A","original_submission_date":"2021-04-16"}},{"id":2157142,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-17T01:02:09.000Z","date":"2021-04-14","kind":"exercise","acquired":true,"shares":35911,"price":4.7,"value":168781.7,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The Original Form 4 incorrectly reported the number of shares acquired from an option exercise as 67,435 due to an administrative error."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The Original Form 4 incorrectly reported the option exercise price for 35,911 shares of the issuer's common stock as $10 due to an administrative error."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount reflects the number of securities beneficially owned after the reported transactions on April 14, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by family trust, of which the reporting person and his spouse are trustees."}],"balance_after":67435,"source":{"system":"sec-edgar","filing":"0001209191-22-050426","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050426/doc4a.xml","form_type":"4/A","original_submission_date":"2021-04-16"}},{"id":2157141,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-17T01:02:09.000Z","date":"2021-04-14","kind":"exercise","acquired":true,"shares":13071,"price":10,"value":130710.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The original Form 4 filed on April 16, 2021 (the \"Original Form 4\") incorrectly reported the option exercise price for 13,071 shares of the issuer's common stock as $4.7 due to an administrative error."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount reflects the number of securities beneficially owned after the reported transactions on April 14, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by family trust, of which the reporting person and his spouse are trustees."}],"balance_after":31524,"source":{"system":"sec-edgar","filing":"0001209191-22-050426","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050426/doc4a.xml","form_type":"4/A","original_submission_date":"2021-04-16"}},{"id":2157140,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-09-17T01:01:21.000Z","date":"2022-09-14","kind":"exercise","acquired":false,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Reflects an initial grant of 16,500 Options granted on June 3, 2022 to directors under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":12375,"derivative":{"exercise_price":1.05,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":4125},"source":{"system":"sec-edgar","filing":"0001209191-22-050425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050425/doc4.xml","form_type":"4"}},{"id":2157139,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-09-17T01:01:21.000Z","date":"2022-09-14","kind":"exercise","acquired":false,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.05,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-050425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050425/doc4.xml","form_type":"4"}},{"id":2157138,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-09-17T01:01:21.000Z","date":"2022-09-14","kind":"exercise","acquired":false,"shares":10230,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.05,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":10230},"source":{"system":"sec-edgar","filing":"0001209191-22-050425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050425/doc4.xml","form_type":"4"}},{"id":2157137,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-09-17T01:01:21.000Z","date":"2022-09-14","kind":"exercise","acquired":false,"shares":7389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.05,"expiration_date":"2029-05-12","underlying":"Common Stock","underlying_shares":7389},"source":{"system":"sec-edgar","filing":"0001209191-22-050425","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050425/doc4.xml","form_type":"4"}},{"id":2157136,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-17T01:01:21.000Z","date":"2022-09-14","kind":"exercise","acquired":true,"shares":4125,"price":1.05,"value":4331.25,"ownership":{"direct":true},"balance_after":421039,"source":{"system":"sec-edgar","filing":"0001209191-22-050425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050425/doc4.xml","form_type":"4"}},{"id":2157135,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-17T01:01:21.000Z","date":"2022-09-14","kind":"exercise","acquired":true,"shares":16500,"price":1.05,"value":17325.0,"ownership":{"direct":true},"balance_after":416914,"source":{"system":"sec-edgar","filing":"0001209191-22-050425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050425/doc4.xml","form_type":"4"}},{"id":2157134,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-17T01:01:21.000Z","date":"2022-09-14","kind":"exercise","acquired":true,"shares":10230,"price":1.05,"value":10741.5,"ownership":{"direct":true},"balance_after":400414,"source":{"system":"sec-edgar","filing":"0001209191-22-050425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050425/doc4.xml","form_type":"4"}},{"id":2157133,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-17T01:01:21.000Z","date":"2022-09-14","kind":"exercise","acquired":true,"shares":7389,"price":1.05,"value":7758.45,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 67,435 shares previously reported as indirectly held through a family trust of which the reporting person and his spouse are trustees.  In accordance with SEC guidance with respect to shares held by living trusts, such shares are now included in the shares directly owned by the reporting person."}],"balance_after":390184,"source":{"system":"sec-edgar","filing":"0001209191-22-050425","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122050425/doc4.xml","form_type":"4"}},{"id":2178055,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-08-19T20:08:12.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":14846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders."}],"balance_after":0,"derivative":{"exercise_price":10.14,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-021380","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000112760222021380/form4.xml","form_type":"4"}},{"id":2178054,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-08-19T20:08:12.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":14846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":2.14,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-021380","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000112760222021380/form4.xml","form_type":"4"}},{"id":2178053,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-08-19T20:08:12.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":14846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders"}],"balance_after":0,"derivative":{"exercise_price":18.63,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-021380","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000112760222021380/form4.xml","form_type":"4"}},{"id":2178052,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-08-19T20:08:12.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":14846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders"}],"balance_after":14846,"derivative":{"exercise_price":2.14,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-021380","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000112760222021380/form4.xml","form_type":"4"}},{"id":2186787,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-12T22:05:04.000Z","date":"2022-08-11","kind":"sale","acquired":false,"shares":10000,"price":59.22,"value":592200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.09 to $59.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":44233,"source":{"system":"sec-edgar","filing":"0001209191-22-045683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122045683/doc4.xml","form_type":"4"}},{"id":2194319,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-05T00:39:02.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":true,"shares":7389,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":7389,"derivative":{"exercise_price":1.05,"expiration_date":"2029-05-12","underlying":"Common Stock","underlying_shares":7389},"source":{"system":"sec-edgar","filing":"0001209191-22-044464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122044464/doc4.xml","form_type":"4"}},{"id":2194318,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-05T00:39:02.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":false,"shares":7389,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":10,"expiration_date":"2029-05-12","underlying":"Common Stock","underlying_shares":7389},"source":{"system":"sec-edgar","filing":"0001209191-22-044464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122044464/doc4.xml","form_type":"4"}},{"id":2194317,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-05T00:39:02.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":true,"shares":10230,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":10230,"derivative":{"exercise_price":1.05,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":10230},"source":{"system":"sec-edgar","filing":"0001209191-22-044464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122044464/doc4.xml","form_type":"4"}},{"id":2194316,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-05T00:39:02.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":false,"shares":10230,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":44.02,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":10230},"source":{"system":"sec-edgar","filing":"0001209191-22-044464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122044464/doc4.xml","form_type":"4"}},{"id":2194315,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-05T00:39:02.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":true,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":16500,"derivative":{"exercise_price":1.05,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-044464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122044464/doc4.xml","form_type":"4"}},{"id":2194314,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-05T00:39:02.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":false,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These Options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":19.7,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-044464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122044464/doc4.xml","form_type":"4"}},{"id":2194313,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-05T00:39:02.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":true,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an initial grant of 16,500 Options granted on June 3, 2022 that vests as follows: One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":16500,"derivative":{"exercise_price":1.05,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-044464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122044464/doc4.xml","form_type":"4"}},{"id":2194312,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-08-05T00:39:02.000Z","date":"2022-08-02","kind":"disposition_to_issuer","acquired":false,"shares":16500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reflects an initial grant of 16,500 Options granted on June 3, 2022 that vests as follows: One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":0,"derivative":{"exercise_price":1.22,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-044464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122044464/doc4.xml","form_type":"4"}},{"id":2222847,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-06-23T20:21:02.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":14846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 21, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":1.17,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-018040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000112760222018040/form4.xml","form_type":"4"}},{"id":2233838,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-13T21:11:13.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":16757,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16757,"derivative":{"exercise_price":55.48,"exercise_date":"2023-06-09","expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":16757},"source":{"system":"sec-edgar","filing":"0001209191-22-036387","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122036387/doc4.xml","form_type":"4"}},{"id":2237833,"issuer":{"id":4734,"kind":"organization","name":"MeiraGTx Holdings plc","symbol":"MGTX"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Share Units","published_at":"2022-06-09T20:53:35.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit converts into one ordinary share upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted share units shall vest in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted share units shall vest in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023."}],"balance_after":15000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-22-006383","document":"form4-06092022_010625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1735438/000141588922006383/form4-06092022_010625.xml","form_type":"4"}},{"id":2237832,"issuer":{"id":4734,"kind":"organization","name":"MeiraGTx Holdings plc","symbol":"MGTX"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-09T20:53:35.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable in a single annual installment upon the earlier of (i) June 7, 2023 or (ii) the day immediately prior to the date of the Issuer's annual meeting of shareholders in 2023."}],"balance_after":15000,"derivative":{"exercise_price":8.25,"expiration_date":"2032-06-07","underlying":"Ordinary Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-22-006383","document":"form4-06092022_010625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735438/000141588922006383/form4-06092022_010625.xml","form_type":"4"}},{"id":2239996,"issuer":{"id":67708,"kind":"organization","name":"Applied Therapeutics, Inc.","symbol":"APLT"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-08T01:21:05.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of Options granted to directors under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":16500,"derivative":{"exercise_price":1.22,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-22-034931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122034931/doc4.xml","form_type":"4"}},{"id":2258705,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-05-24T20:34:36.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":346026,"source":{"system":"sec-edgar","filing":"0001035443-22-000170","document":"wf-form4_165342445154816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000170/wf-form4_165342445154816.xml","form_type":"4"}},{"id":2271719,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-13T21:24:37.000Z","date":"2019-06-18","kind":"exercise","acquired":false,"shares":14189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On June 18, 2018, the reporting person was granted 14,189 restricted stock units, vesting on the first anniversary of the grant date (June 18, 2019)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On June 18, 2018, the reporting person was granted 14,189 restricted stock units, vesting on the first anniversary of the grant date (June 18, 2019)."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":14189},"source":{"system":"sec-edgar","filing":"0001209191-22-028919","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122028919/doc4.xml","form_type":"4"}},{"id":2271718,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T21:24:37.000Z","date":"2022-05-12","kind":"sale","acquired":false,"shares":10000,"price":55,"value":550000.0,"ownership":{"direct":true},"balance_after":54233,"source":{"system":"sec-edgar","filing":"0001209191-22-028919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122028919/doc4.xml","form_type":"4"}},{"id":2271717,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T21:24:37.000Z","date":"2019-06-18","kind":"exercise","acquired":true,"shares":14189,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,297 shares previously reported as sold from the reporting person's direct holdings, which were actually sold by Alexandria Real Estate Equities, Inc."}],"balance_after":64233,"source":{"system":"sec-edgar","filing":"0001209191-22-028919","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122028919/doc4.xml","form_type":"4"}},{"id":2309031,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-04-04T21:30:53.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":24560,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":343526,"source":{"system":"sec-edgar","filing":"0001035443-22-000113","document":"wf-form4_164910782307434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000113/wf-form4_164910782307434.xml","form_type":"4"}},{"id":2341392,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-10T02:49:48.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":10000,"price":52.89,"value":528900.0,"ownership":{"direct":false,"nature":"Held by the Joel S. Marcus and Barbara A. Marcus Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.72 to $53.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":28980,"source":{"system":"sec-edgar","filing":"0001209191-22-017755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122017755/doc4.xml","form_type":"4"}},{"id":2341391,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-10T02:49:48.000Z","date":"2022-03-08","kind":"sale","acquired":false,"shares":5000,"price":52.25,"value":261250.0,"ownership":{"direct":false,"nature":"Held by the Joel S. Marcus and Barbara A. Marcus Family Trust"},"balance_after":38980,"source":{"system":"sec-edgar","filing":"0001209191-22-017755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122017755/doc4.xml","form_type":"4"}},{"id":2341390,"issuer":{"id":81206,"kind":"organization","name":"Intra-Cellular Therapies, Inc.","symbol":"ITCI"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-10T02:49:48.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":5000,"price":54.52,"value":272600.0,"ownership":{"direct":false,"nature":"Held by the Joel S. Marcus and Barbara A. Marcus Family Trust"},"balance_after":43980,"source":{"system":"sec-edgar","filing":"0001209191-22-017755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1216955/000120919122017755/doc4.xml","form_type":"4"}},{"id":2436149,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2022-01-13T21:52:43.000Z","date":"2022-01-11","kind":"grant","acquired":true,"shares":16869,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":318966,"source":{"system":"sec-edgar","filing":"0001035443-22-000017","document":"wf-form4_164211074803292.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544322000017/wf-form4_164211074803292.xml","form_type":"4"}},{"id":2607265,"issuer":{"id":419,"kind":"organization","name":"ALEXANDRIA REAL ESTATE EQUITIES, INC.","symbol":"ARE"},"owners":[{"id":21789,"kind":"person","name":"MARCUS JOEL S","position":1,"cik":"0001216955","reported_name":"MARCUS JOEL S","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2021-08-11T21:22:24.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":7500,"price":207.61,"value":1557075.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold at prices ranging from $207.40 to $208.00.  The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":302097,"source":{"system":"sec-edgar","filing":"0001035443-21-000219","document":"wf-form4_162871692499614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035443/000103544321000219/wf-form4_162871692499614.xml","form_type":"4"}}],"next_cursor":"2021-08-11T21:22:24.000000Z,2607265"}